Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000702944 | SCV000831821 | pathogenic | Nephronophthisis 16 | 2017-09-07 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg461*) in the ANKS6 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs369437168, ExAC 0.002%). This variant has not been reported in the literature in individuals with ANKS6-related disease. Loss-of-function variants in ANKS6 are known to be pathogenic (PMID: 23793029, 25599650). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000702944 | SCV005677536 | likely pathogenic | Nephronophthisis 16 | 2024-05-16 | criteria provided, single submitter | clinical testing |